- Home
- OPK vs LENZ Comparison
OPK vs LENZ Comparison
Compare OPK & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPK
- LENZ
- Stock Information
- Founded
- OPK 2007
- LENZ 2019
- Country
- OPK United States
- LENZ United States
- Employees
- OPK N/A
- LENZ N/A
- Industry
- OPK Biotechnology: Pharmaceutical Preparations
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- OPK Health Care
- LENZ Health Care
- Exchange
- OPK Nasdaq
- LENZ Nasdaq
- Market Cap
- OPK 1.0B
- LENZ 1.1B
- IPO Year
- OPK 1995
- LENZ 2021
- Fundamental
- Price
- OPK $1.39
- LENZ $41.29
- Analyst Decision
- OPK Buy
- LENZ Strong Buy
- Analyst Count
- OPK 4
- LENZ 4
- Target Price
- OPK $2.75
- LENZ $49.75
- AVG Volume (30 Days)
- OPK 1.9M
- LENZ 415.8K
- Earning Date
- OPK 11-06-2025
- LENZ 11-05-2025
- Dividend Yield
- OPK N/A
- LENZ N/A
- EPS Growth
- OPK N/A
- LENZ N/A
- EPS
- OPK N/A
- LENZ N/A
- Revenue
- OPK $664,029,000.00
- LENZ $5,000,000.00
- Revenue This Year
- OPK N/A
- LENZ N/A
- Revenue Next Year
- OPK $0.84
- LENZ $258.37
- P/E Ratio
- OPK N/A
- LENZ N/A
- Revenue Growth
- OPK N/A
- LENZ N/A
- 52 Week Low
- OPK $1.11
- LENZ $16.54
- 52 Week High
- OPK $2.04
- LENZ $42.77
- Technical
- Relative Strength Index (RSI)
- OPK 51.88
- LENZ 58.81
- Support Level
- OPK $1.34
- LENZ $39.62
- Resistance Level
- OPK $1.44
- LENZ $41.80
- Average True Range (ATR)
- OPK 0.04
- LENZ 2.00
- MACD
- OPK -0.00
- LENZ -0.11
- Stochastic Oscillator
- OPK 50.00
- LENZ 75.17
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.